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1. Introduction  
Papillomaviruses are small, nonenveloped, double-stranded DNA viruses, which infect a 
wide variety of vertebrate species and induce proliferative lesions in their host. The viruses 
are species-specific and to date, more than 150 different types of papillomaviruses have been 
identified; each virus infects a specific region of cutaneous or internal mucosal epithelium in 
its host (McLaughlin-Drubin and Münger, 2009). Papillomaviruses are widely spread in 
nature and in most cases, papillomavirus infections are cleared by the host immune system, 
however, sometimes papillomaviruses establish persistent infections. Papillomavirus 
classification is based on nucleotide sequence homology (de Villiers et al., 2004). Human 
papillomavirus (HPV) types that infect the genital epithelia belong to subgroup A (alpha-
papillomaviruses), and are classified into high- or low-risk types, depending upon their 
oncogenic potential. Persistent infection with high-risk HPVs (HPV16, 18, 31, 33, 45) can 
lead to cervical cancer, the second most common cancer in women (Durst et al., 1983; zur 
Hausen, 2000). Low-risk HPVs, such as HPV6 and 11, can infect genital tract as well as oral 
sites where they are generally associated with benign papillomas. The second major group 
of HPVs, supergroup B, also known as beta-papillomaviruses, infect skin epithelia and may 
develop skin cancers at the site of HPV infection (McLaughlin-Drubin and Münger, 2009).  
2. Papillomavirus life cycle 
Papillomaviruses, with the help of only few genes, can achieve a complete replication cycle 
in the epidermal and mucosal keratinocytes. Most viral types are predominantly trophic for 
one or the other cell types, but certain genotypes can infect and persist in both. 
Papillomavirus virions enter the epithelial tissue through microwounds and infect a subset 
of basal cells, probably stem cells, at low copy number (Egawa, 2003). HPV virions migrate 
to the cell nucleus and establish their genomes as episomes. Next, the HPV early promoter is 
activated and the viral early proteins, E1 and E2, are transcribed, the synthesis of viral DNA 
is initiated and the copy number of viral episomes is raised up to 20-100 genomes per cell. 
During this amplification stage, rapid viral replication is required to quickly reach an 
optimal copy number. As basal cells divide, HPV genomes are replicated and distributed 
evenly between daughter cells in mitosis. This is a phase of episomal maintenance with 
minimal viral gene expression, viral replication proceeds at moderate level and is 
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synchronized to cellular proliferation (De Geest et al., 1993). Papillomavirus persistence is 
set up through the maintenance of a constant copy number of extrachromosomal viral 
genomes in the nuclei of dividing host cells. The expression of late genes encoding the 
capsid proteins and virus assembly are tightly coupled to the differentiation of epithelial 
tissue (Longworth and Laimins, 2004). When the infected keratinocyte enters the 
differentiating compartment, exiting the cell cycle, the vegetative phase of the HPV life cycle 
leading to amplification of the viral genome is initiated. This phase includes amplification of 
viral copy number to at least 1000 copies per cell and expression of late transcripts encoding 
proteins for viral capsid. The viral DNA is packed into virions, which are released with dead 
cells after the infected cells reach the epithelial surface (for review, see Chow et al. 2010; 
Doorbar, 2005).  
The dependence of papillomavirus life cycle on epithelial differentiation and difficulties in 
reproducing this process in cell culture has complicated the studies of papillomavirus 
replication. Short-term replication assays closely mimic the initial amplification phase of 
replication, while long-term replication assays mimic viral maintenance in undifferentiated 
basal cells. DNA amplification and virion assembly can be analyzed only in differentiating 
epithelial cells. The most extensively studied papillomavirus is bovine papillomavirus type-
1 (BPV-1) because of its capacity to transform rodent cell lines in culture (Law et al., 1981). 
The mouse fibroblast cell line C127 transfected with the BPV1 genome maintaining the viral 
DNA as extrachromosomal plasmid with the constant copy number was historically the first 
model system for studying mechanisms of papillomavirus DNA replication. Our knowledge 
of initiation of papillomavirus DNA replication and maintenance of virus genomes has 
primarily derived from studies with BPV1. However, BPV-1 belongs to delta-
papillomaviruses and is evolutionary distinct from the human papillomaviruses.  
 
 
Fig. 1. Schematic representation of epithelia showing various differentiated layers and PV 
replication, and cell culture models mimicking papillomavirus DNA replication. 
The limited availability of appropriate cell culture systems supporting HPV DNA 
replication has hampered research of HPV replication and regulatory pathways involved in 
these processes. Primary keratinocytes, transfected with circulized HPV genome, replicate 
HPV genomes at low copy number. Productive HPV replication needs culture systems 
where epithelial cells are able to differentiate. Adaptation of organotypic culture techniques, 
„raft“ culture systems, provide the basis for propagation of HPVs, although the yield of 
virions is very low (Dollard et al., 1992; McCance et al., 1988; Meyers et al., 1992). 
Introduction of adenovirus recombinants carrying the HPV genome flanked by loxP sites 
and Cre recombinase into PHK cells grown in raft cultures results in efficient establishment 
of cells harboring thousands of copies of the HPV18 genome. Virions obtained from these 
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cultures efficiently infect PHKs at a multiplicity of infection (MOI) of <50, resulting in 
expression of spliced viral mRNAs (Wang et al., 2009a). However, organotypic culture of 
HPV-infected cells is not a very convenient system for long-term viral persistence and 
latency studies. Cell lines from mild dysplasia harboring episomal HPV genomes (W12 and 
CIN-612) have been very useful tools for studying stable episomal HPV replication, and also 
loss of episomes and integration of HPV into the host genome, a process accompanied by 
tumourigenesis (Pett and Coleman, 2007). At early passages in monolayer culture, the W12 
cells retain HPV16 episomes at 100 to 200 copies per cell, but in long-term cultivation in the 
absence of feeder cells, the spontaneous loss of episomes and integration of HPV16 occurs 
(De Geest et al., 1993; Pett et al., 2004; Stanley et al., 1989). The genomes of both high- and 
low-risk alpha-papillomaviruses as well as cutaneous beta-papillomaviruses replicate in 
human osteosarcoma cell line U2OS, and are able to establish persistent replication in these 
cells. These cell lines might be a valuable and efficient tool for studying fundamental 
properties of HPV DNA replication, especially the long-term viral persistence, and for the 
development of inhibitors of HPV genome replication (Geimanen et al., 2011). 
2.1 Papillomavirus genome 
All papillomaviruses have a similar genomic organization. The papillomavirus genome of 
approximately 8000 base pairs in length contains a non-coding upstream regulatory region 
(URR), early (E) region of open reading frames (ORFs) and late (L) region of ORFs. The 
circular papillomavirus genome encodes roughly eight ORFs from a single DNA strand. The 
URR alone is 600-900 base pairs in length and contains the origin of replication and binding 
sites for transcription factors and enhancers (Fig. 2). All transcription takes place in the same 
direction (clockwise on the circular map) using multiple promoters. The E region and L 
region are both followed by a poly-A addition site. Within the virions, the papillomavirus 
genome is associated with cellular histones forming chromatin-like complexes. 
Papillomavirus transcription is complex and involves the usage of different promoters, 
multiple splice patterns and differential production of mRNA species in different cells. In 
BPV1, seven different promoters, six of which being active in undifferentiated cells, have 
been identified (Ahola et al., 1987; Baker and Howley, 1987). In the high-risk HPV types, 
transcripts are initiated at two major viral promoters, one for early and the other for late 
transcripts. In contrast, early genes of low-risk HPVs are expressed from two independent 
promoters (Chow et al., 1987). The HPV early promoter (p105 in case of HPV18) is activated 
by binding of cellular transcription factors; however the factors that determine the cell 
specificity are still not fully understood. Among the main players involved in PV replication 
are the ubiquitous transcription factors Sp1 and AP1 (Gloss and Bernard, 1990; Hubert et al., 
1999; Thierry, 2009; Thierry et al., 1992). In addition to the binding sites for the cellular 
transcription factors, the URR contains binding sites for the virally encoded E2 regulatory 
proteins and E1 helicase. Early region proteins, E6, E7, E1 and E2 are transcribed from the 
HPV early promoter active in basal, nonproductively infected cells and in transformed cells, 
and all four early proteins are translated from the same polycistronic mRNA (Hummel et 
al., 1992). E1 and E2 are directly involved in viral DNA replication; the other early proteins - 
oncoproteins E6 and E7 - support viral DNA amplification indirectly by inactivating major 
tumor suppressor proteins and activating signal transduction pathways (for review, see 
(McLaughlin-Drubin and Münger, 2009; Moody and Laimins, 2010).  
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Fig. 2. Organization of the HPV18 circular genome showing the cis-sequences and viral 
proteins required for initiation of papillomavirus DNA replication. Open reading frames are 
indicated by dark grey (early region) and light grey (late region) boxes. The origin of 
replication, early promoter (p105) and E2 binding sites (boxes with numbers) are shown on 
the scheme of URR. Papillomavirus E1 and E2 proteins, transcribed from the early promoter, 
form a complex and bind cooperatively to their binding sites within the origin of replication 
locating in the URR. 
3. Papillomavirus DNA replication  
3.1 Initiation of replication 
The double-stranded circular DNA replicates as a multi-copy extrachromosomal plasmid in 
the nucleus of infected cells. The replication of papillomavirus DNA is initiated from the 
origin of replication consisting of binding sites for E1 and E2 proteins (Del Vecchio et al., 
1992; Ustav et al., 1993; Ustav et al., 1991). Transient, short-term replication requires the 
origin of replication in cis and the expression of viral E1 and E2 proteins, all other replication 
enzymes and proteins are supplied by the host cells (Remm et al., 1992; Ustav and Stenlund, 
1991). Papillomavirus DNA replication is not cell-type specific, despite of high degrees of 
host and cell-type specificity for infection. The BPV1 genome can replicate and is maintained 
in murine C127 cells. HPV11 and HPV18 genomic DNA can replicate not only in its natural 
host cells, primary foreskin keratinocytes, but also in the human tongue squamous cell 
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carcinoma cell line SCC4 and osteosarcoma cell line U2OS (Del Vecchio et al., 1992; 
Geimanen et al., 2011; Mungal et al., 1992). Transient replication of BPV1 and HPV origin-
containing plasmids can take place in a number of mammalian cells if E1 and E2 proteins 
are provided from heterologous expression vectors (Chiang et al., 1992). HPV transcription 
exhibits stringent cell specificity and the lack of regulated gene expression of viral early 
proteins from HPV genomes could be the reason that restricts HPV genome replication to 
certain cell types. BPV1 DNA replication in vitro with purified proteins and cell extracts 
from murine, simian and human cells has been reconstituted showing that all cellular 
factors essential for papillomavirus DNA replication are provided by the host cell (Liu et al., 
1995; Muller et al., 1994; Yang et al., 1991a). The cellular replication factors required for 
papillomavirus DNA replication include replication protein A (RPA), a single-stranded-
DNA-binding protein, replication factor C (RFC), proliferating-cell nuclear antigen (PCNA) 
and DNA polymerase ┙–primase. It has been shown that E1 recruits Topo I to the 
papillomavirus replication fork and Topo I specifically stimulates the origin binding activity 
of papillomavirus E1 protein (Clower et al., 2006; Hu et al., 2006; Melendy et al., 1995; Park 
et al., 1994). 
3.2 Origin of replication 
The papillomavirus origin of replication consists of three E2 binding sites (E2BS), from 
which only one is absolutely required for replication, and an A/T-rich region containing an 
array of E1 protein binding sites (E1BS) (Remm et al., 1992; Ustav et al., 1991). The overall 
structure of BPV1 and HPV origins is conserved and various combinations of E1 and E2 
proteins from different papillomaviruses can initiate DNA replication from several 
papillomavirus origins (Chiang et al., 1992; Del Vecchio et al., 1992; Kadaja et al., 2007). A 
relationship appears to exist between the affinity of the E2BS and the ability to function at a 
distance from the binding site for the E1 protein. A low-affinity site appears to be functional 
only when located close to the E1 binding site, while for function at greater distances higher 
affinities are required. In multimerized form, the high affinity E2BSs are able to function 
even when placed at a distance of one kilobase from the rest of the origin (Ustav et al., 1993).  
High-risk HPV genomes have been found integrated into host chromatin in tumors and 
cervix dysplasia biopsy specimens of patients (Dall et al., 2008; Kristiansen et al., 1994). 
Integration of the HPV genome is often accompanied by the disruption of E2 open reading 
frame and the loss of E2 activity, leading to enhanced expression of virus oncogenes E6 and 
E7. The HPV regulatory sequences are active in cervical cancer cells as expression of E7 
promotes cell survival (Jiang and Milner, 2002). In patients, the HPV16 genome may exist at 
the same time in episomal as well as in an integrated form. Co-existence of the replicating 
episomal viral genome expressing the viral E2 protein, and integrated HPV with viral 
replication origin raises the question about the functionality of the integrated origins. Recent 
works have shown that expression of E1 and E2 proteins from expression vectors or from 
different HPV genomes can induce replication of the genomic integrated HPV origin.  The 
replication forks initiated at the integrated HPV origins extend into the flanking regions of 
cellular DNA, and these amplified genomic sequences could be targets for the 
recombination and repair system. This suggests that replication induced from the 
papillomavirus integrated origin may induce genomic changes of the host cell (Kadaja et al., 
2009; Kadaja et al., 2007). 
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Fig. 3. Origin of replication of BPV1 and HPV18. E1 binding sites are depicted with arrows 
and E2 binding sites with boxes. The minimal origin of replication consisting of E1BS and 
E2BSs is shown for BPV1 and HPV18, and the minichromosome maintenance element MME, 
required for maintenance and segregation of viral DNA, for BPV1. 
3.3 Assembly of the DNA replication initiation complex 
E1 is an initiator protein of papillomavirus DNA replication. E1 is responsible for 
recognition of the replication origin, melting of the DNA at the origin as well as for 
subsequent unwinding of the double helix during progression of the replication fork. The 
viral E1 protein is an ATP-dependent helicase which binds as a dimer to pairs of its binding 
sites (Yang et al., 1993). The binding sites for the E1 replication helicase are short sequences, 
5-6 base pairs in length, arranged as two pairs of inverted repeats (Chen and Stenlund, 1998; 
Chen and Stenlund, 2001). E1 has low sequence specificity and therefore it can initiate DNA 
replication in vitro, and from non-specific DNA sequences (Bonne-Andrea et al., 1995). 
Within the cells, the E1 and E2 proteins form a complex through multiple protein-protein 
interactions and bind cooperatively to adjacent binding sites in the origin of replication 
(Berg and Stenlund, 1997; Mohr et al., 1990). E1 by itself binds to the origin with low degree 
of sequence specificity, but in the presence of E2 the sequence specificity is increased 
(Sedman and Stenlund, 1995; Sedman et al., 1997). In this process, E2 functions transiently 
and “catalytically”, providing sequence specificity for the formation of the E1-ori complex. 
In addition, E2 enhances E1 binding to DNA through the DNA-binding domain by 
inhibiting the non-specific DNA binding of the E1 helicase domain (Stenlund, 2003a). The 
E1-E2-ori complex is able to bind DNA with high specificity but lacks other biochemical 
activities. In the next step, additional E1 molecules are added by displacing E2 from the 
DNA-bound complex in an ATP-dependent manner (Sanders and Stenlund, 1998; Sanders 
and Stenlund, 2000). Two additional E1 molecules are recruited to the origin, which results 
in the formation of two E1 trimers on the ori, followed by formation of two hexamers in the 
presence of ATP. E1 hexameric complex has the DNA helicase activity which is able to 
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unwind the DNA and initiate the papillomavirus DNA replication (Fouts et al., 1999; Schuck 
and Stenlund, 2005; Sedman and Stenlund, 1998).  
 
 
Fig. 4. Assembly of the replication initiation complex. The E1 and E2 proteins bind 
cooperatively to the origin of replication, which contains binding sites for both proteins 
(E1BS and E2BS). The resulting E1:E2 complex binds DNA with high affinity and specificity. 
In the next step, additional E1 molecules are recruited to the complex and E2 is displaced in 
the presence of ATP. ATP hydrolysis is also required for conversion of E1 complex into a 
double hexamer possessing DNA helicase activity (for review, see Stenlund, 2003b). 
3.4 Stable maintenance replication 
Papillomaviruses have the capacity to establish a persistent infection in mammalian 
epithelial cells. The BPV1-transformed C127 cells maintain the viral genome as a multicopy 
nuclear plasmid thus being a valuable tissue culture system for investigating the 
establishment and maintenance of papillomavirus genomic DNA. The studies with BPV1-
C127 cells have revealed that during the maintenance of virus genomes BPV1 DNA is 
replicating by a conventional bi-directional (theta-type) replication mode throughout S 
phase of the cell cycle in a random-choice fashion (Gilbert and Cohen, 1987; Ravnan et al., 
1992). Some molecules replicate once per cell cycle, some replicate more than once, and 
others do not replicate at all during a given cell cycle, resulting in statistically “once per cell 
cycle” replication of the viral DNA. Stable HPV DNA replication seems to be more 
complicated. This has been studied in human keratinocytes, where the HPV DNA is stably 
maintained at high copy number over several passages. HPV16 and HPV31 DNA can 
replicate randomly or in an ordered once-per-S-phase fashion depending on the cell line in 
which it is located. In W12 cells, which are derived from a natural cervical lesion, the HPV16 
DNA replicates only once per S phase, but in another immortalized keratinocyte cell line, 
NIKS, it replicates randomly (Hoffmann et al., 2006). At later stages of the papillomavirus 
life cycle, there is a shift from the theta replication mode in the proliferating keratinocytes to 
the rolling-circle replication mode after the cells start to differentiate (Flores and Lambert, 
1997).  
Studies of subclones of BPV1-transformed C127 cells as well as U2OS cells maintaining HPV 
genomes have demonstrated cell to cell variation in the extent and state of genomic DNA. In 
addition to the monomeric form of genomic DNA, dimeric and sometimes higher oligomeric 
forms of BPV1 and mucosal and cutaneous HPV genomes are detected. Oligomeric forms of 
papillomavirus DNA are organized in a head-to-tail configuration and replication is 
initiated at only some of the origins (Geimanen et al., 2011; Schvartzman et al., 1990). In 
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patient samples, HPV16 DNA, which is maintained in carcinoma cells as episome, is always 
multimeric, suggesting that oligomerization of HPV genomes is common during viral 
infections in vivo (Cullen et al., 1991; Kristiansen et al., 1994).  
It is widely accepted that the E1 and E2 proteins are essential for long-term stable 
replication. However, some studies suggest that E1 is necessary to establish the viral 
genome as a nuclear plasmid, but is not required at the maintenance stage. The replication 
of the BPV1 genome containing temperature-sensitive mutation in the E1 gene was first 
initiated at the permissive temperature and then switched to the non-permissive 
temperature, where ts-E1 genomes were found to persist as nuclear plasmids for multiple 
cell generations (Kim and Lambert, 2002).  
The functions of viral oncoproteins E6 and E7 are also essential for the maintenance of the 
extrachromosomal forms of HPV DNA (Thomas et al., 1999). Both E6 and E7 stimulate cell 
cycle progression and may create a cellular environment permissive to HPV maintenance 
and abrogate the checkpoints that would block the long-term retention of viral DNA 
(Garner-Hamrick et al., 2004). Oncogene expression in basal epithelial cells is shown to 
inhibit cellular differentiation thus promoting long-term persistence of HPV episomes 
(Hudson et al., 1990; Jones et al., 1997; Sherman and Schlegel, 1996). The E6 and E7 proteins 
of high-risk HPV types act as viral oncogenes. E6 binds the p53 tumor suppressor protein, 
which regulates the expression of proteins involved in cell cycle control, leading to 
degradation of p53 (Scheffner et al., 1990; Werness et al., 1990). Another important function 
of the high-risk E6 protein is the activation of telomerase in infected cells. High-risk HPV E6 
has been shown to increase telomeric length by activating the catalytic subunit of the 
telomerase hTERT. This extends the life of epithelial cells containing HPV genomes (Oh et 
al, 2001; Stoppler et al., 1997). The function of the high-risk E7 protein is the binding and 
degradation of the RB family proteins, which are the major regulators of the cell cycle (Boyer 
et al., 1996; Schmitt et al., 1994). E7 interaction with histone deacetylases HDACs plays also 
an essential role in the viral life cycle, as cells harboring HPV genomes with mutations 
abolishing the E7-HDAC interaction display slower growth and a loss of episomal 
maintenance (Longworth and Laimins, 2004a). Integration of high-risk HPV into the host 
genome and loss of E2 expression leads to constitutive activation of the viral oncogenes. 
Reintroduction of E2 into HPV-associated cervical carcinoma cells, resulting in reactivation 
of p53 and pRB pathways, has shown to suppress cellular growth, because of cell cycle 
arrest in G1, apoptosis and senescence (Desaintes et al., 1997; Goodwin and DiMaio, 2000; 
Goodwin et al., 2000; Hwang et al., 1996; Thierry et al., 2004; Wells et al., 2000).  
4. E2 as a viral regulatory protein 
The proteins encoded by the papillomavirus E2 ORF play a crucial role in the viral life cycle 
and serve as major viral regulators of transcription, replication and segregation of the viral 
genome in the infected cells. The E2 protein is a modular protein consisting of three 
different structural as well as functional domains; the N-terminal transactivation domain 
(TAD) (aa 1-200), the C-terminal DNA-binding dimerization domain (DBD) (aa 310-410), 
and flexible unstructured “hinge region” which functions as a linker between the two 
domains. The carboxy-terminal DBD binds as a dimer to consensus sequence ACCN6GGT 
(Androphy et al., 1987) and the N-terminal activation domain is required for the replication, 
transactivation and segregation function of the protein (Abroi et al., 2004; Bastien and 
McBride, 2000; McBride et al., 1989; Ustav and Stenlund, 1991). The three-dimensional 
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structures of the C-terminal DBD and N-terminal transactivation domain of several E2 
proteins have been reported revealing a tight dimer of the DBD bound to DNA and a L-
shape structure of activation domain (Antson et al., 2000; Harris and Botchan, 1999; Hegde 
et al., 1992). The papillomavirus E2 proteins can function as activators or repressors of 
transcription depending on the concentration of proteins within the cell. At low 
concentrations, E2 activates, and at high concentrations, suppresses transcription from 
homologous and heterologous promoters containing E2 binding sites (Abroi et al., 1996; 
Schweiger et al., 2007). E2 has been demonstrated to be a transcriptional activator of early 
genes in BPV1 and a repressor of early genes in case of HPV16 (Soeda et al., 2006; Spalholz 
et al, 1985; Thierry and Yaniv, 1987).  
E2 is a multifunctional protein. The transactivation domain of E2 is responsible for 
interactions with viral helicase E1 and with several cellular proteins. The transactivation and 
replication functions of E2 are separable by point-mutations in the N-terminal activation 
domain (Abroi et al., 1996; Brokaw et al., 1996; Ferguson and Botchan, 1996; Grossel et al., 
1996). The X-ray crystal structures of a complex containing the activation domain of E2 and 
the helicase domain of E1, and the activation domain of E2 together with Brd4 have been 
solved and confirm that E2 interacts with E1 and Brd4 through different interaction surfaces 
(Abbate et al., 2004; Abbate et al., 2006). The cellular bromodomain protein Brd4 is the major 
cellular partner for E2, and interaction with Brd4 is crucial for both E2 transactivation and 
repression functions (Ilves et al., 2006; McPhillips et al., 2006; Schweiger et al., 2006). Brd4 is 
a component of the HPV11 E2 transcriptional silencing complex involved in repression of 
the E6/E7 promoter (Wu et al., 2006). Through the interaction of Brd4 and transactivation 
domain, E2 is associated with transcriptionally active cellular chromatin. This association is 
driving the E2-mediated tethering of viral genomes to host chromatin, and at the same time 
is retaining the viral genomes in transcriptionally active regions of the nucleus to escape 
silencing (Jang et al., 2009; Kurg et al., 2005). The transactivation domain mediates 
functional interactions with cellular transcription factors Sp1 and AP1, histone acetylase 
complexes containing CBP/p300 and pCAF, and with nucleosome assembly protein hNAP1 
(Lee et al., 2002a; Lee et al., 2000; Li et al., 1991; Müller et al., 2002; Rehtanz et al., 2004; 
Thierry et al., 1992). E2-dependent activities are also modulated by interactions with Brm, a 
chromatin remodeling protein associated with SWI/SNF ATP-dependent chromatin 
remodeling complex, and with EP400, a component of the NuA4/TIP60 histone acetylase 
complex, and SMCX, also known as histone demethylase JARID1C , and Tax1BP1 (Kumar et 
al., 2007; Smith et al., 2010; Wang et al., 2009b).  
E2 binds to the papillomavirus oncoproteins E6 and E7, leading to the modulation of their 
functions (Gammoh et al., 2006; Grm et al., 2005). E2 has activities that inhibit cell growth. 
High-risk, but not low-risk HPV E2 proteins can induce themselves growth arrest and 
apoptotic cell death in several HPV-negative carcinoma cell lines. Apoptosis can occur via a 
p53-dependent as well as independent pathways (Demeret et al., 2003; Parish et al., 2006b). E2 
binds to the cellular protein p53. Expression of p53 can inhibit papillomavirus DNA 
replication and alter the transcriptional activity of E2 (Frattini et al., 1997; Lepik et al., 1998; 
Massimi et al., 1999). Interestingly, p53 inhibits the initial, amplificational replication, but not 
the stable, long-term replication of BPV1 (Ilves et al., 2003). E2 can modulate the activity of 
cellular proteins, like activators of the Anaphase Promoting Complex (APC) Cdh1 and Cdc20 
inducing genomic instability (Bellanger et al., 2005). E2 is associated with transcriptionally 
active chromatin and as a transcription factor may directly regulate the expression of cellular 
genes. The HPV E2 proteins are reported to repress the hTERT promoter activity (Lee et al., 
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2002b). HPV8 E2 protein suppresses ┚4-integrin expression and HPV16 E2 protein 
transcriptionally activates the promoter of a key cellular splicing factor SF2/ASF (Mole et al., 
2009; Oldak et al., 2004). The expression of HPV8 E2 protein in transgenic mice can induce the 
formation of skin tumors through an unknown mechanism (Pfefferle et al., 2008).  
The E2 proteins bind to inverted repeats with consensus sequence 5’ ACCGN4CGGT, where 
N4 represents a 4 bp central sequence (Li et al., 1989). Although the base pairs in the central 
spacer sequence are not in contact with the protein, they affect protein binding. The E2 DNA 
binding is accompanied by bending of DNA and depends on DNA flexibility (Hines et al., 
1998). HPV E2 proteins bind with higher affinity to sites with A/T-rich central spacer while 
BPV1 E2 has no preference (Dell et al., 2003). E2 binding can be inhibited by CpG 
methylation of the E2 binding site (Kim et al., 2003; Thain et al., 1996). The BPV1 genome 
contains 17 E2 binding sites from which 12 sites are located within the URR region. In 
genital HPV genomes, there are four E2 binding sites with conserved sequences and 
positions. E2 remains associated with the BPV1 URR throughout the cell cycle including 
mitosis (Melanson and Androphy, 2009).  
 
 
Fig. 5. Papillomavirus genomes encode multiple E2 proteins. In addition to the full-length 
E2 protein, BPV1 and HPV18 genomes encode truncated E2 proteins, which lack the 
activation domain and serve as repressors of replication and transcription. The full-length 
and truncated E2 proteins are able to form dimers through their common C-terminal DNA-
binding-dimerization domain. 
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4.1 E2 repressors and heterodimers 
In addition to the full-length E2 protein, the BPV-1 and mucosal HPV genomes encode 
truncated E2 proteins, which lack the activation domain, but maintain the DNA-binding-
dimerization domain (DBD). For BPV1, mRNA for E2C is transcribed from a promoter internal 
to the open reading frame, and E8/E2 is created by splicing E8 ORF sequences to an acceptor 
located within the E2 ORF. The repressor proteins encoded by HPVs are similar to the BPV1 
E8/E2 protein, since they contain a small conserved E8 ORF (HPV 11, 18, 31) or fragment of E1 
ORF (HPV 11) fused to the C-terminus of E2. Transient over-expression assays have suggested 
that shorter E2 proteins act as negative regulators of E2 and function as repressors of 
transcription and replication (Chiang et al., 1991; Doorbar et al., 1990; Hubbert et al., 1988; 
Kurg et al., 2010; Lim et al., 1998; Stubenrauch et al., 2000). The shorter E2s antagonize the 
function of full-length E2 by competing for E2 DNA binding sites. In addition, the E8 of HPV 
31 E8/E2 protein itself is a transcriptional repressor domain that functions independently of 
binding site competition inhibiting transcription and DNA replication by interacting with co-
repressor molecules such as NCoR1/HDAC3, the histone methyltransferase SETDB1, and the 
TRIM28 protein (Ammermann et al., 2008; Powell et al., 2010). 
The full-length and truncated E2 proteins are able to form dimers through their common C-
terminal DNA-binding-dimerization domain (McBride et al., 1989). E2 heterodimers with 
single activation domain bind DNA sequence-specifically and serve as activators of 
transcription and replication in cell culture model systems (Kurg et al., 2006). E2 
heterodimers can interact with viral helicase E1, and are able to recruit E1 to the origin of 
replication and activate the papillomavirus DNA replication in a cell-free system (Lim et al., 
1998). Replacing the open reading frame of E2 with “single-chain” E2 in the context of BPV1 
and HPV18 genome revealed that E2 heterodimer with single activation domain could 
support transient, but not long-term, replication in cell culture model systems (Kurg et al., 
2009; Kurg et al., 2010). The full-length E2 protein is required for long-term papillomavirus 
DNA replication, the E2 heterodimer with single activation domain is crippled in this 
function. E2 requires two activation domains for interaction with Brd4, the cellular receptor 
for BPV1 E2 on mitotic chromosomes. Brd4 interacts efficiently with the BPV1 homodimer 
with two activation domains and with low affinity with the E2 heterodimer with single 
activation domain and with E2 mutants unable to form dimers between N-terminal 
activation domains (Cardenas-Mora et al., 2008; Kurg et al., 2006; You et al., 2004).  
4.2 The role of E2 in initiation of DNA replication 
The expression of E2 protein is required for initiation of papillomavirus DNA replication. 
The role of E2 in initiation of viral DNA replication is relatively well understood, E2 helps to 
recruit the viral helicase E1 to the viral replication origin by direct protein-protein and 
protein-DNA interactions as discussed above. The initiation step and interactions mediating 
the formation of the replication initiation complex are well studied and are conserved 
between BPV1 and alpha-papillomaviruses.  
4.3 The role of E2 in stable maintenance 
Segregation of papillomavirus genomic DNA is achieved through its attachment to mitotic 
host chromosomes during cell division. Non-covalent association of viral DNA with 
chromosomes is a general mechanism used by all papillomaviruses studied so far. This 
mechanism ensures that the replicated virus episomes are retained inside the nuclei of 
dividing host cells and faithfully partitioned to the daughter cells during mitosis (You, 2010).  
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Long-term replication and maintenance of BPV1 episomes requires the sequence of URR - 
the minichromosome maintenance element (MME) - consisting of at least six E2 binding 
sites and the minimal origin of replication as cis-elements. The plasmids containing BPV1 
URR can be maintained as extrachromosomal elements in hamster CHO cells stably 
expressing the viral E1 and E2 proteins (Piirsoo et al., 1996). Extrachromosomal MME-
containing plasmids containing ten oligomerized E2 binding sites segregate efficiently 
between daughter cells in the presence of E2 protein expressed from the same plasmid 
(Abroi et al., 2004; Silla et al., 2005). MME consisting of E2 binding sites and the E2 protein 
are responsible for anchoring of BPV1 genomes as well as URR reporter plasmids to host 
cell chromosomes (Ilves et al., 1999; Lehman and Botchan, 1998; Skiadopoulos and McBride, 
1998). The functional organization of the HPV URR is significantly different from that of the 
BPV1. Alpha-papillomavirus genomes have four E2 binding sites in this region and only 
three of them are required for stable replication (Stubenrauch et al., 1998). The exact 
mechanism of segregation of HPV genomes is not yet known and needs further 
investigations. 
 
 
Fig. 6. Papillomaviruses establish persistent infection by maintaining viral genomes as 
episomes in host cell. (A) During mitosis, papillomavirus genomes are associated with 
cellular mitotic chromosomes. (B) For many papillomaviruses, association with mitotic 
chromosomes is mediated by the viral E2 protein and cellular bromodomain protein Brd4. 
The role of E2 in long-term stable replication is not yet fully understood. The maintenance of 
papillomavirus genomes during latency is achieved by tethering viral genomes to host the 
mitotic apparatus in dividing cells. In this, BPV1 and HPVs may use different targets to 
achieve their goal. In BPV1, the activation domain of E2 is attached to chromosomes and the 
DNA-binding-dimerization domain tethers viral genomes to achieve their accurate 
segregation during mitosis. The point-mutations in the activation domain of E2, disrupting 
the transcription activity of E2, affect the chromatin attachment, suggesting that this activity 
is required for efficient segregation and maintenance of MME-containing plasmids (Abroi et 
al., 2004). The cellular receptor for BPV1 E2 on mitotic chromosomes is the bromodomain 
protein Brd4 (You et al., 2004). However, E2 proteins from different papillomaviruses 
interact with Brd4 with different affinities. E2 proteins of alpha-papillomaviruses interact 
with Brd4 weakly and do not co-localize with Brd4 on host mitotic chromosomes, 
suggesting that HPV E2 proteins may use different cellular targets for tethering virus 
www.intechopen.com
 The Role of E2 Proteins in Papillomavirus DNA Replication 
 
625 
genomes to host chromosomes (McPhillips et al., 2005; Oliveira et al., 2006). DNA helicase 
ChR1, a member of the mammalian cohesion complex, is a candidate partner for cellular 
receptor of HPV E2. ChlR1 and E2 co-localize at early stages of mitosis, however, during 
prometaphase, ChlR1 is localized to the spindle poles, suggesting that ChlR1 may help to 
load the papillomavirus E2 protein onto mitotic chromosomes during early mitosis (Parish 
et al., 2006a). HPV16 E2 co-localizes with TopBP1, a cellular protein involved in DNA 
damage response, on chromatin and centrosomes during late telophase, suggesting that 
TopBP1 could be the mitotic chromatin receptor for HPV16 E2 (Donaldson et al., 2007). On 
the other hand, E2 proteins of HPV11, HPV16 and HPV18 have been found to localize to 
centrosomes and mitotic spindles during cell division (Van Tine et al., 2004). MKlp2, mitotic 
kinesin-like protein 2, a kinesin-like motor protein of the central mitotic spindle, binds and 
co-localizes with papillomavirus E2 during mitosis (Yu et al., 2007). The beta-papillomavirus 
HPV8 E2 protein binds to the repeated ribosomal DNA loci that are found on the short arm 
of human acrocentric chromosomes. These speckles do not contain Brd4, the E2 protein co-
localizes with UBF, the RNA polymerase I transcription factor (Poddar et al., 2009). A recent 
study using chimeric BPV1 E2 proteins has shown that attachment of the protein to 
chromatin is not sufficient for proper segregation. Successful partitioning of virus genomes 
during cell division is determined by effective formation of the segregation-competent 
complex which does not necessarily involve the Brd4 protein (Silla et al., 2010).   
4.4 Regulation of replication by E2 
The relative abundance of E2 proteins within the cell is an important factor regulating 
papillomavirus DNA replication. In BPV1-transformed cells, the relative ratio of E2 proteins 
is 1:5:1.5 for E2-E2C-E8/E2. The truncated E2 repressor proteins predominate in the steady 
state and the E2 heterodimers with single activation domain formed between the full-length 
and truncated E2 proteins are the preferential form for E2 (Kurg et al., 2006). The promoters 
for full-length E2 as well as for repressors are themselves controlled and differently 
regulated by E2, and furthermore, the ratio of the repressors to activators changes 
throughout the cell cycle. In G1 cells, the repressors dominate, but in late S phase and G2/M, 
the activator is present at about equal levels to that of the repressors. So, the level of E2 
activators and repressors as well as E2 homo- and heterodimers is changing suggesting that 
the balance of different E2 proteins is a key event in the regulation of papillomavirus DNA 
replication (Szymanski and Stenlund, 1991; Yang et al., 1991b).  
In papillomaviruses, there is a link between transcription and replication control, the protein 
that binds specifically to origin of replication also functions in control of transcription. BPV1 
E2 protein levels are regulated by E2 itself and E2 activators and/or repressors have a 
positive or negative feedback to virus DNA replication. Initially the level of E2 activators is 
high to facilitate DNA amplification after infection, but later, the E2 expression is strictly 
controlled to avoid over-replication. Genetic studies have shown that the E8/E2 protein of 
HPV18, 31 and at least one of the BPV1 repressors are required for the long-term 
maintenance of virus episomes, demonstrating the important role of E2 repressors in the 
viral life cycle. Deletion of the E8 ORF results in robust initial replication of HPV genomes 
followed by rapid loss of virus episomes from dividing cells. The role of E2 repressors in the 
virus life cycle is to modulate the activity of full-length E2 protein by preventing the E2 
binding to E2BS via binding site competition, and by acting as a repressor recruiting host co-
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repressor molecules (Kurg et al., 2010; Lambert et al., 1990; Stubenrauch et al., 2000). 
However, the persistent replication and maintenance of virus genomes is not affected in E8 
knock-out genomes of HPV16 and cotton-tail rabbit papillomavirus (CRPV), suggesting that 
E2 proteins of different papillomaviruses may regulate their expression and through this 
replication by different ways (Jeckel et al., 2003; Lace et al., 2008). 
The efficiency of papillomavirus DNA replication is also controlled by the level of the E1 
protein. E2 regulates E1 expression level through modulation of the activity of viral early 
promoters (Hubert and Laimins, 2002; Szymanski and Stenlund, 1991). However, it is still 
not clear to what extent HPV E2 proteins regulate HPV URRs. The HPV16 E2 protein does 
not repress HPV16 transcription when the URR is contained within an episomal HPV 
genome (Bechtold et al., 2003). Another group has shown that transcription activation 
function of the HPV31 E2 protein is not required for the viral life cycle (Stubenrauch et al., 
1998). In addition to the transcriptional regulation by E2, the expression of E1 is regulated 
post-transcriptionally by mRNA splicing. In high-risk HPVs, E1 is translated by a 
discontinuous scanning mechanism and mRNA splicing within the E6 ORF is required for 
efficient expression of E1 (Hubert and Laimins, 2002)(Remm et al., 1999). 
5. Conclusion 
E2 is the master regulator of extrachromosomal replication of papillomaviruses. E2 regulates 
papillomavirus replication at multiple levels and through different mechanisms. First, E2 is 
essential for initiation of papillomavirus DNA replication. Second, E2 is required for long-
term stable replication and is involved in maintenance and segregation of viral genomic 
DNA. Third, the abundance of E2 proteins and formation of homo- and heterodimers 
possessing different activities as well as the expression level of viral helicase E1 is regulated 
by E2. In addition to direct involvement in replication, E2 indirectly regulates 
papillomavirus replication through modulation of expression and activity of viral 
oncogenes E6 and E7, and the cellular environment.  
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